These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29321429)

  • 1. Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection.
    Fujiwara K; Yasui S; Haga Y; Nakamura M; Yonemitsu Y; Arai M; Kanda T; Oda S; Yokosuka O; Kato N
    Intern Med; 2018 Jun; 57(11):1543-1552. PubMed ID: 29321429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
    Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
    J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure.
    Dao DY; Seremba E; Ajmera V; Sanders C; Hynan LS; Lee WM;
    Dig Dis Sci; 2012 May; 57(5):1349-57. PubMed ID: 22198704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of fulminant acute Hepatitis B with nucles(t)id analogues is safe and does not lead to secondary chronification of Hepatitis B.
    Jochum C; Maischack F; Anastasiou OE; Verheyen J; Timm J; Bechmann L; Gerken G; Canbay A
    Z Gastroenterol; 2016 Dec; 54(12):1306-1311. PubMed ID: 27936480
    [No Abstract]   [Full Text] [Related]  

  • 5. Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
    Pellicelli AM; Barbaro G; Francavilla R; Romano M; Barbarini G; Mazzoni E; Mecenate F; Paffetti A; Barlattani A; Struglia C; Villani R; Nauri L; Nosotti L; Armignacco O; Ferri F; Camporiondo MP; Soccorsi F;
    Clin Ther; 2008 Feb; 30(2):317-23. PubMed ID: 18343270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
    Lee WC; Wu MJ; Cheng CH; Chen CH; Shu KH; Lian JD
    Am J Kidney Dis; 2001 Nov; 38(5):1074-81. PubMed ID: 11684562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
    Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
    Tillmann HL; Zachou K; Dalekos GN
    Liver Int; 2012 Apr; 32(4):544-53. PubMed ID: 22099371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
    Bowden S; Locarnini S; Chang TT; Chao YC; Han KH; Gish RG; de Man RA; Yu M; Llamoso C; Tang H
    World J Gastroenterol; 2015 Apr; 21(15):4644-51. PubMed ID: 25914474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae.
    Jochum C; Gieseler RK; Gawlista I; Fiedler A; Manka P; Saner FH; Roggendorf M; Gerken G; Canbay A
    Digestion; 2009; 80(4):235-40. PubMed ID: 19828954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B.
    Fujiwara K; Yasui S; Okitsu K; Yonemitsu Y; Oda S; Yokosuka O
    J Gastroenterol; 2010 Dec; 45(12):1255-62. PubMed ID: 20614156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study.
    Maklad S; Doss W; El Din SS; Hassan K; Zeid AA
    Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.
    Son CY; Ryu HJ; Lee JM; Ahn SH; Kim DY; Lee MH; Han KH; Chon CY; Park JY
    Liver Int; 2012 Aug; 32(7):1179-85. PubMed ID: 22452737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
    Ołdakowska-Jedynak U; Paczek L; Foroncewicz B; Mucha K; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Ziółkowski J; Pilecki T; Patkowski W; Górnicka B; Paczkowska A; Krawczyk M
    Ann Transplant; 2007; 12(3):28-32. PubMed ID: 18290567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of lamivudine on acute-on-chronic liver failure in patients with chronic hepatitis B].
    Xiao L; Qi JH; Shi XF; Sun YC; Yan XZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):438-41. PubMed ID: 23044201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
    Chen YC; Chuang MK; Chou NK; Chi NH; Wu IH; Chen YS; Yu HY; Huang SC; Wang CH; Tsao CI; Ko WJ; Wang SS
    Transplant Proc; 2012 May; 44(4):910-2. PubMed ID: 22564582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
    Acar A; Görenek L; Aydin A; Eyigün CP; Eken A; Sayal A; Pahsa A
    Mikrobiyol Bul; 2009 Jul; 43(3):411-23. PubMed ID: 19795616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result.
    Cai S; Yu T; Jiang Y; Zhang Y; Lv F; Peng J
    Clin Exp Med; 2016 Aug; 16(3):429-36. PubMed ID: 26164128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of antiviral treatment on patients with acute-on-chronic hepatitis B liver failure with low viral load].
    Chen LB; Cao H; Zhang YF; Shu X; Chen N; Zhang K; Li G; Xu QH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):364-6. PubMed ID: 21280326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia.
    Delić D; Nesić Z; Prostran M; Boricić I; Svirtlih N
    Vojnosanit Pregl; 2009 Mar; 66(3):199-202. PubMed ID: 19341224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.